Skip to main content

Table 2 Haplotypes of CDNF2 in stage 2 patients with SZ

From: Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population

Haplotype

Case (freq)

Control (freq)

Chi square

P value

Odds ratio (95% CI)

CAGAG

157.87 (0.57)

169.89 (0.50)

2.25

0.13

1.29 (0.94–1.78)

TGATC

45.87 (0.17)

82.00 (0.24)

6.38

0.01

0.61 (0.41–0.92)

TGATG

43.00 (0.16)

57.90 (0.17)

0.30

0.58

0.88 (0.57–1.35)

TGGAG

30.13 (0.11)

26.11 (0.08)

2.61

0.11

1.44 (0.83–2.51)

  1. Significant value has been emphasized by italic
  2. CI confidence interval